Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00352872
Recruitment Status : Terminated (This study has been difficult to recruit.)
First Posted : July 17, 2006
Last Update Posted : March 2, 2018
Information provided by (Responsible Party):
Bryan Schneider, Indiana University

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : January 13, 2009
  Actual Study Completion Date : January 13, 2009